Catalyst Wire Dossier Catalyst Wire Dossier

WAL 801 CL Dry Syrup

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for WAL 801 CL Dry Syrup, covering 2014-07-14 to 2014-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers [Phase 1]

See pricing